Dermatologic Laser Surgery

Garden, Jerome M.; Geronemus, Roy G.

doi:10.1111/j.1524-4725.1990.tb00035.x

Cited by 49 publications

(18 citation statements)

References 72 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Since the patient had a long-standing history of DLE and local corticosteroids as well as systemic therapy with antimalarials for several months had shown no improvement of the telangiectatic skin lesions on the face, argon laser therapy was tried as an alternative method. The argon laser emits a visible, blue- green, continuous-wave beam of 488–514 nm with a skin penetration of 1–2 mm and operates at only a few watts of power [18, 19]. This light is preferentially absorbed by the red color of hemoglobin and is converted to heat, which leads to red cell destruction and thrombosis of small blood vessels.…”

Section: Discussionmentioning

confidence: 99%

Successful Treatment of Discoid Lupus erythematosus with Argon Laser

et al. 2000

View full text Add to dashboard Cite

Vascular lesions with telangiectasias on visible areas, such as the face, are common in discoid lupus erythematosus (DLE); however, an efficient management of these skin lesions can sometimes be difficult. Since argon laser light is able to specifically coagulate vascular structures, it has been used in the treatment of various vascular skin malformations. Therefore, we addressed the issue whether argon laser treatment could be a therapeutic alternative for this disease. Here, we report on a patient with DLE, who suffered from long-standing erythematous, telangiectatic plaques on the face refractory to standard regimens of therapy. After 2 laser applications, a significant improvement was observed and after 5 sessions of argon laser therapy the treated skin lesions had completely resolved with an excellent cosmetic result. The patient tolerated the laser treatment well without any short-term side effects. These data indicate that argon laser therapy might be a powerful alternative approach in the treatment of vascular skin lesions of DLE.

show abstract

Section: Discussionmentioning

confidence: 99%

Successful Treatment of Discoid Lupus erythematosus with Argon Laser

et al. 2000

View full text Add to dashboard Cite

show abstract

“…During Discoid lupus erythematous is a chronic inflammatory skin condition notorious for causing disfiguring scars and alopecia. Since 1986, lasers have been introduced as an alternative treatment approach for refractory skin lesions of DLE (6)(7)(8). However, lasers already been used for treatment of these lesions have been high power lasers with varying amount of adverse effects (9) ( Table 1).…”

Section: Discussionmentioning

confidence: 99%

Successful Treatment of Resistant Discoid Lupus Erythematous (DLE) With Low-Level Laser Therapy (LLLT): A Case Report

Kazemikhoo

Mansouri

2015

J Skin Stem Cell

View full text Add to dashboard Cite

Introduction: Lupus is a chronic autoimmune illness characterized by production of autoantibodies against nuclear antigens. Lupus may also only appear as a skin disease. Discoid lupus erythematous (DLE), the most common form of chronic cutaneous lupus erythematous is characterized by patches of persistent erythema, adherent scaling, follicular plugging and, in the later stages scaring and atrophy. Case Presentation: The case was a 33-year-old female with two years history of DLE, who referred to the laser clinic of Milad hospital with acute flare of skin lesions since seven months ego. She had four lesions (three with local alopecia, scaling and itching and one with atrophy). Serological studies for antinuclear antibodies and anti Ro/SS-A antibody were negative. After five sessions of treatment with infrared (830 nm; 200 mw) and red light (630 nm; 20 mw) diode laser in addition to intravenous red light laser (655 nm; 2 mw) for 20 minutes and laser acupuncture with infrared diode laser (1 J/cm 2 ) for six acupuncture points every other day, the beneficial effects started to appear, and after nine sessions, local itching of the lesions had stopped. Through a total of 27 sessions of treatment, the lesions improved completely with highly satisfactory results; and drug-therapy held to be continued. No disease flare up was seen after the one-year follow up. Conclusions:To the best of our knowledge, this is the first case report on low-level laser therapy (LLLT) treatment of DLE. Low-level laser therapy may be effective in treating inflammatory lesions such as cutaneous lesions of discoid lupus erythematous. More studies with higher sample size are needed to clarify the role of low level lasers in treating such lesions.

show abstract

“…It only has modest specificity for tissue chromophores such as melanin, blood, etc., and penetrates to a depth of 5– 6 mm into the tissue. When used as a free beam, it has a high degree of scatter, causing a large volume of nonspecific tissue to be coagulated [1]. …”

Section: The Nd:yag Lasermentioning

confidence: 99%